Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc.（CRBP）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crbp · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$44.00
Consensus
$38.50
+409.3% upside
Low
$33.00
Median: $38.5 · Last Close: $7.56
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$38.50
409.3% upside
High Target
$44
482.0%
Low Target
$33
336.5%
Current Price
$7.56
as of today
Based on analyst price targets, the CRBP stock price prediction for the next 12 months ranges from $33 to $44. The consensus CRBP price forecast of $38.50 implies 409.3% upside from the current price of $7.56.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.18 | ↓ 5.00% |
1-day model range: $7.05–$7.31. Peak: $7.31 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -62.5% |
| 2029 | $2 | -67.2% |
| 2030 | $2 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRBP · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-22 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-05-13 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-13 | Jefferies | Maintains | Buy→Buy |
| 2026-03-10 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-11-13 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-10-20 | Wedbush | Maintains | Outperform→Outperform |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock. Of the recent 51 rating actions, 2 were upgrades and 3 were downgrades. 16 analysts currently cover CRBP.
分析师推荐趋势
CRBP analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 6 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↓ 63.1% YoY
Revenue Next Year
$4M
↑ 116.0% YoY
EPS This Year
$-4.64
EPS Next Year
$-5.15
↑ 10.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRBP EPS of $-4.64 for the current fiscal year, based on estimates from 8 analysts. The CRBP revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRBP 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRBP 的共识目标价为 $38.50（+409.3% 上行空间），分析师共识为 Buy。
CRBP 的短期预测（明日）为 $7.18（-5.00%）。 CRBP 对 2027 年的股价预测均值为 $4。 CRBP 对 2030 年的预测区间为 $2–$3。
Corbus Pharmaceuticals Holdings, Inc. 在 NASDAQ 上市，代码 CRBP。CRBP 在 2027 年的整体展望偏积极，在覆盖分析师中约 88% 对应 Buy 共识。
常见问题
CRBP 预测 · 8 个问题根据 16 位华尔街分析师，CRBP 的 12 个月平均目标价为 $38.50，最高 $44.00、最低 $33.00。若有图表，中位目标价可在上方查看。相对当前价 $7.56，隐含约 +409.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.